MedPath

Nitrofurantion

Nitrofurantoin Capsules, USP (Macrocrystals) 25 mg, 50 mg and 100 mg Rx Only

Approved
Approval ID

d8c68797-47a9-2956-e053-2a95a90a0149

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 24, 2022

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nitrofurantion

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-2647
Application NumberANDA201722
Product Classification
M
Marketing Category
C73584
G
Generic Name
Nitrofurantion
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 24, 2022
FDA Product Classification

INGREDIENTS (11)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
POTASSIUM HYDROXIDEInactive
Code: WZH3C48M4T
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
NITROFURANTOINActive
Quantity: 100 mg in 1 1
Code: 927AH8112L
Classification: ACTIB
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nitrofurantion - FDA Drug Approval Details